Let’s talk about seeing through skin, not metaphorically, but medically. MediView XR just locked in a $24M Series A led by GE HealthCare, with Cleveland Clinic, Mayo Clinic, Edge Ventures, and JobsOhio Growth Capital Fund all jumping in. This isn’t just capital, it’s conviction that surgical vision is entering its XR era. Founded in 2017 by John Black and Adam E. Rakestraw, J.D., MediView spun out of Cleveland Clinic IP and three patents that reimagined what doctors could see inside the OR.
Fast-forward, and MediView’s flagship XR90 gives clinicians real-time 3D “X-ray vision,” fusing CT scans with live ultrasound so anatomy, tissue, and vasculature appear as holograms hovering within view. No guesswork, no glancing away, just precision. Peer-reviewed data from the Journal of Medical Imaging backs it with 2.3mm TRE and 4.4mm IFRE accuracy. When the FDA granted 510(k) clearance in July 2023, the 1st ever for an AR system combining live imaging + 3D visualization, MediView didn’t waste a beat. By November, the XR90 powered its first clinical procedure at New York-Presbyterian/Weill Cornell Medical Center.
At the wheel is CEO & President Mina Fahim, a biomedical engineer who built his career at Medtronic before scaling this Cleveland-born startup into a serious surgical player. Co-founder & Chairman Adam E. Rakestraw handles the business moves, while CTO Glenn Raudins transforms advanced visualization into surgeon-friendly tech. Add in operators like COO Adam Cargill, VP of Commercial & Customer Success Darcy Bajko, and VP of Finance Erik Keener, and you’ve got a team mixing science, hustle, and commercial IQ in perfect proportion.
Partnerships? Stacked. GE HealthCare’s OmnifyXR Interventional Suite integrates MediView’s platform directly into its ultrasound systems. Cleveland Clinic stays deeply tied as the origin point of its core IP. Mayo Clinic adds clinical insight through a research collaboration that keeps the tech battle-tested. This is what happens when R&D, clinical practice, and product execution all play in rhythm.
The AR surgical navigation market is projected to hit $6.05B by 2033 with 17.8% CAGR. MediView’s not waiting for it, they’re building it. The XR90 lets surgeons maintain natural hand-eye coordination, visualize in 3D, and collaborate remotely as if distance never existed. It’s the kind of advancement that turns imagination into instrumentation.
$24M later, they’re not just enhancing vision, they’re redefining what it means to truly see medicine.
